Clinical trials
Completed Phase 2 Thrombocythemia, Essential trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2002 | 2 |
| 2004 | 3 |
| 2005 | 3 |
| 2006 | 5 |
| 2007 | 3 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2020 | 1 |
| 2021 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 35 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 6 |
| National Cancer Institute (NCI) | 4 |
| H. Lee Moffitt Cancer Center and Research Institute | 2 |
| Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA) | 2 |
| M.D. Anderson Cancer Center | 2 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2 |
| Case Comprehensive Cancer Center | 1 |
| Cephalon | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Galena Biopharma, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thrombocythemia, Essential | 35 |
| Polycythemia Vera | 30 |
| Primary Myelofibrosis | 27 |
| Myeloproliferative Disorders | 20 |
| Leukemia, Myelomonocytic, Chronic | 14 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 12 |
| Multiple Myeloma | 11 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 11 |
| Leukemia, Myeloid, Acute | 10 |
| Lymphoma, Non-Hodgkin | 10 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.